New MenaQ7® Vitamin K2 Patents Granted
Successful examination period results in process patents in United States, Israel, and AustraliaOSLO, NORWAY and METUCHEN, NJ (7 November 2017) – NattoPharma ASA has announced it has successfully secured patents in Israel, the United States, and Australia for its nature-identical synthesis creating MenaQ7® PharmaPure Vitamin K2 as MK-7, enriching the company’s already robust patent portfolio. • Israel: On July 31, 2017 patent #238199 “Process for preparation of MK-7 type of Vitamin K2” was granted. • United States: On August 28, 2017 Notice of Allowance for patent #14/435,260 “